INE416D01022
INE416D01022
BLISS GVS PHARMA LTD.
Loading chart...
Company Profile
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
5Y Volatility
50.1% p.a.
Max Drawdown (5Y)
-41.3%
Sharpe Ratio (5Y)
0.80
Beta Factor
1.22
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 51.2 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (56.9%) is noticeably higher than the 5Y average (50.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.9% in the extended horizon.